Search research articles
Contact Us
Filters
Showing results (241-250 of 356) with videos related to
Page
of 36
Sort By:
JACC. Advances
|
June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of Hypertension
Nelson Wang, Phidias Rueter, Abdul Salam, et al.
Drug and Alcohol Dependence
|
May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey
Dilara Bahceci, Krista Siefried, Maureen Steele, et al.
Journal of Human Hypertension
|
February 21, 2024
The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study
Liping Huang, Qiang Li, Jason Hy Wu, et al.
JAMA
|
September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial
Simon Thom, Neil Poulter, Jane Field, et al.
European Heart Journal
|
November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges
, Salim Yusuf, Amir Attaran, et al.
Open Heart
|
December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension
Simone Marschner, Mark D Huffman, Desi Quintans, et al.
Journal of Human Hypertension
|
July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps
Catherine G Derington, Kyle Tong, Joshua A Jacobs, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
May 25, 2026
Blood pressure lowering for the prevention of REcurrent stroke and Cardiovascular outcomes After acute intracerebral haemorrhage: protocol for an individual Participant data meta-analysis of randomised controlled trials (RECAP-ICH)
M J Velasco, Yijie Gao, Shitian Li, et al.
The Lancet. Rheumatology
|
January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
JingWei Li, Sunil V Badve, Zien Zhou, et al.
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
Page
of 36
Search research articles
Search
Showing results (241-250 of 356) with videos related to
Sort By:
Page
of 36
JACC. Advances
|
June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of Hypertension
Nelson Wang, Phidias Rueter, Abdul Salam, et al.
Drug and Alcohol Dependence
|
May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey
Dilara Bahceci, Krista Siefried, Maureen Steele, et al.
Journal of Human Hypertension
|
February 21, 2024
The contribution of sodium reduction and potassium increase to the blood pressure lowering observed in the Salt Substitute and Stroke Study
Liping Huang, Qiang Li, Jason Hy Wu, et al.
JAMA
|
September 5, 2013
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial
Simon Thom, Neil Poulter, Jane Field, et al.
European Heart Journal
|
November 30, 2013
Combination pharmacotherapy to prevent cardiovascular disease: present status and challenges
, Salim Yusuf, Amir Attaran, et al.
Open Heart
|
December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension
Simone Marschner, Mark D Huffman, Desi Quintans, et al.
Journal of Human Hypertension
|
July 4, 2026
Patient out-of-pocket costs for antihypertensive single pill combination products with cost caps
Catherine G Derington, Kyle Tong, Joshua A Jacobs, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
May 25, 2026
Blood pressure lowering for the prevention of REcurrent stroke and Cardiovascular outcomes After acute intracerebral haemorrhage: protocol for an individual Participant data meta-analysis of randomised controlled trials (RECAP-ICH)
M J Velasco, Yijie Gao, Shitian Li, et al.
The Lancet. Rheumatology
|
January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
JingWei Li, Sunil V Badve, Zien Zhou, et al.
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
Page
of 36